Clinical Trial Update: Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells for Dilated Cardiomyopathy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for autologous bone marrow mononuclear stem-cell transplantation in dilated cardiomyopathy; the Phase 2/3 study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• Autologous bone marrow mononuclear stem-cell transplantation

Snippet

Sponsor: Instituto de Cardiologia do Rio Grande do Sul | Conditions: Dilated Cardiomyopathy | Phase 2, Phase 3 | Status: COMPLETED